Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
17.2% CAGR, driven by provincial delivery variation and benefit design
These symptoms can easily be mistaken for side effects of the GLP-1 medication itself, leading to mismanagement
Wegovy is licensed for weight management, type 2 diabetes, and was the first GLP-1 medication approved by the MHRA as a preventative treatment for obese and overweight adults with serious heart problems
However, patients with conditions requiring fluid restriction (such as heart failure or advanced kidney disease) should follow their healthcare provider's specific guidance regarding fluid intake
They should be viewed as a potential complement to a holistic weight management program, not as a stand-alone solution for weight loss
